Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants and
is associated with increased mortality, respiratory morbidity, neurodevelopmental …

Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly affecting extremely
preterm infants. Although mechanical ventilation and oxygen requirements in premature …

Preterm infants with bronchopulmonary dysplasia (BPD), and particularly those who develop
the most severe forms of chronic lung disease during the neonatal period, are at high risk for …

The American Academy of Pediatrics continues to provide guidance on the use of postnatal
corticosteroids to manage or prevent chronic lung disease following preterm birth (formerly …

Importance Meta-analyses suggest that corticosteroids may be associated with increased
survival without cerebral palsy in infants at high risk of bronchopulmonary dysplasia (BPD) …

Bronchopulmonary dysplasia (BPD) is a common morbidity affecting preterm infants and is
associated with substantial long-term disabilities. There has been no change in the …

Bronchopulmonary Dysplasia (BPD) is a multifactorial disease affecting over 35% of
extremely preterm infants born each year. Despite the advances made in understanding the …

Although advances in the respiratory management of extremely preterm infants have led to
improvements in survival, this progress has not yet extended to a reduction in the incidence …

Background Postnatal dexamethasone (PND) is used in high-risk preterm infants after the
first week of life to facilitate extubation and prevent bronchopulmonary dysplasia (BPD) but …

The purpose of this review is to describe the current state of the art in clinical imaging for
NICU patients, divided into major areas that correspond to likely phenotypes of neonatal …